BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

– Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –

– Patient reported efficacy outcomes show a material decrease in pain and increase in function –